(Q26830495)

T. Rampias

series ordinal

2

1 reference

J. B. Vermorken

series ordinal

3

1 reference

language of work or name

1 reference

November 2014

1 reference

1 reference

25

1 reference

PubMed

issue

11

1 reference

PubMed

page(s)

2101-15

1 reference

PubMed

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

The role of human papillomavirus in nongenital cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Molecular mechanisms of HPV induced carcinogenesis in head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Gene expression profiles in HPV-infected head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Human papillomavirus and survival of patients with oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

New treatment strategies for HPV-positive head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU265